2026-08-13
Innovative Drug Yivoksizumab (trade name: Yidafang®) Approved for New Indication in First-Line Treatment of Advanced Squamous Cell Lung Cancer
Kangfang Biotech's innovative drug Yivoksizumab (trade name: Yidafang®) has been approved by the National Medical Products Administration for a new...